Dxcover Expands Leadership Team with Clinical and Commercial Experts
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read MorePosted by CLP Edit Staff | Aug 22, 2025 | Company News |
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read MorePosted by CLP Edit Staff | Aug 21, 2025 | Molecular Diagnostics |
The Salt Lake City-based company offers four targeted testing options that focus on how genetics influence responses to nutrition, fitness, sleep, and stress management.
Read MorePosted by CLP Edit Staff | Aug 20, 2025 | Molecular Diagnostics |
VMD4Kids test, now used by 30-40 pediatric hospitals nationwide for difficult-to-diagnose cases, targets 218 gene variants in mosaic disorders.
Read MorePosted by CLP Edit Staff | Aug 19, 2025 | Sequencing Systems |
New whole exome and transcriptome sequencing assay demonstrates high concordance with existing companion diagnostics while requiring minimal tissue input for biomarker detection.
Read MorePosted by CLP Edit Staff | Aug 19, 2025 | Molecular Diagnostic Analyzers |
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Read More